Carlyle Group Inc. — 13F Holdings & Portfolio
CIK 1527166 · latest 13F-HR filed 2026-05-08
Carlyle Group Inc. manages $10.62B in 13F-reported U.S. long-equity assets across 20 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are MDLN (78.40%), SARO (20.58%), PHAT (0.37%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 1 new position, exited 1, added to 3, and trimmed 15.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$10.62B
Long-equity book
20
Distinct positions
2026-03-31
Filed 2026-05-08
+1 / −1 / ↑3 / ↓15
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- Q32 Bio Inc$3.5M +95.7%
- Onkure Therapeutics Inc$345.5K +44.8%
- Spyre Therapeutics Inc$170.2K +54.0%
Top Trims
- Standardaero Inc-$2.19B -50.1%
- Medline Inc-$717.5M -7.9%
- Phathom Pharmaceuticals Inc-$19.1M -33.0%
- Pony Ai Inc-$12.0M -34.9%
- Getty Images Holdings Inc-$3.4M -40.8%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | Medline Inc | MDLN | 58507V107 | $8.33B | 78.40% | 187,083,713 | SH |
| 2 | Standardaero Inc | SARO | 85423L103 | $2.18B | 20.58% | 84,587,035 | SH |
| 3 | Phathom Pharmaceuticals Inc | PHAT | 71722W107 | $38.8M | 0.37% | 3,496,808 | SH |
| 4 | Pony Ai Inc | PONY | 732908108 | $22.3M | 0.21% | 2,362,447 | SH |
| 5 | Invitation Homes Inc | INVH | 46187W107 | $16.5M | 0.16% | 664,100 | SH |
| 6 | CubeSmart | CUBE | 229663109 | $8.1M | 0.08% | 220,500 | SH |
| 7 | Q32 Bio Inc | QTTB | 746964105 | $7.1M | 0.07% | 1,102,741 | SH |
| 8 | Getty Images Holdings Inc | GETY | 374275105 | $4.9M | 0.05% | 6,234,252 | SH |
| 9 | Spruce Biosciences Inc | SPRB | 85209E208 | $2.5M | 0.02% | 38,620 | SH |
| 10 | Forward Air Corp | FWRD | 34986A104 | $1.8M | 0.02% | 107,214 | SH |
| 11 | Adicet Bio Inc | ACET | 007002207 | $1.3M | 0.01% | 184,295 | SH |
| 12 | Krispy Kreme Inc | DNUT | 50101L106 | $1.2M | 0.01% | 340,748 | SH |
| 13 | Onkure Therapeutics Inc | OKUR | 68277Q105 | $1.1M | 0.01% | 269,895 | SH |
| 14 | Jasper Therapeutics Inc | JSPR | 471871202 | $934.2K | 0.01% | 1,066,189 | SH |
| 15 | SunPower Inc | SPWR | 20460L104 | $550.1K | 0.01% | 433,158 | SH |
| 16 | Heartflow Inc | HTFL | 42238D107 | $497.3K | 0.00% | 20,438 | SH |
| 17 | Spyre Therapeutics Inc | SYRE | 00773J202 | $485.2K | 0.00% | 9,620 | SH |
| 18 | N-able Inc | NABL | 62878D100 | $437.7K | 0.00% | 93,732 | SH |
| 19 | Exicure Inc | XCUR | 30205M309 | $239.6K | 0.00% | 56,328 | SH |
| 20 | Robinhood Mkts Inc | HOOD | 770700102 | $234.0K | 0.00% | 3,376 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-08 | $10.62B | 20 | 0000898432-26-000339 |
| 2025-12-31 | 2026-02-13 | $13.57B | 20 | 0000898432-26-000105 |